Cervomed Inc (CRVO)

02:14 AM

Why CervoMed Inc. (DP8) stock is a strong analyst pickEarnings Performance Report & Risk Managed Trade Strategies - Newser

02:14 AM

Dec 04, 2025

CervoMed’s DLB drug shows promise in phase 2b trial - Investing.com

Dec 04, 2025

Dec 04, 2025

Cervomed (CRVO) Unveils Promising Phase 2b Trial Results for Nef - GuruFocus

Dec 04, 2025

Dec 04, 2025

CervoMed stock soars after promising dementia drug trial results - Investing.com

Dec 04, 2025

Dec 04, 2025

CervoMed Inc. Reports Phase 2b RewinD-LB Trial Results for Neflamapimod, Showing Significant Improvements in Dementia with Lewy Bodies Patients - Quiver Quantitative

Dec 04, 2025

Dec 04, 2025

CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies - GlobeNewswire Inc.

Dec 04, 2025

Dec 04, 2025

How rising interest rates impact CervoMed Inc. stockPortfolio Value Report & Safe Swing Trade Setups - Newser

Dec 04, 2025

Dec 04, 2025

Is CervoMed Inc. stock attractive after correctionJuly 2025 Action & Fast Exit and Entry Strategy Plans - Newser

Dec 04, 2025

Dec 04, 2025

What RSI levels show for CervoMed Inc. (DP8) stockPortfolio Update Report & Low Drawdown Investment Strategies - Newser

Dec 04, 2025

Dec 04, 2025

Why CervoMed Inc. (DP8) stock stays undervaluedM&A Rumor & Short-Term High Return Strategies - Newser

Dec 04, 2025

Dec 03, 2025

CervoMed's (CRVO) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat

Dec 03, 2025

Dec 02, 2025

CervoMed (CRVO) Maintains Buy Rating with Target Price of $31 | - GuruFocus

Dec 02, 2025

Dec 02, 2025

CervoMed (CRVO) Unveils Promising Phase 2b Trial Results for Alz - GuruFocus

Dec 02, 2025

Dec 02, 2025

Neflamapimod reduces key neurodegeneration markers in DLB study By Investing.com - Investing.com UK

Dec 02, 2025

Dec 02, 2025

CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB) - Sahm

Dec 02, 2025

Dec 02, 2025

How CervoMed Inc. (DP8) stock gains from tech spending2025 Volume Leaders & Free Real-Time Volume Trigger Notifications - Newser

Dec 02, 2025

Dec 02, 2025

Will CervoMed Inc. (DP8) stock benefit from Fed rate cutsShare Buyback & AI Powered Market Entry Ideas - Newser

Dec 02, 2025

Nov 27, 2025

What analyst consensus says on CervoMed Inc. stockRecession Risk & Free Fast Gain Swing Trade Alerts - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

CervoMed Inc. (CRVO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 26, 2025

Nov 26, 2025

CervoMed Reports Third Quarter 2025 Financial Results and Provides Corporate Updates - ADVFN

Nov 26, 2025

Nov 26, 2025

CervoMed Inc Stock Analysis and ForecastVolume Profile Analysis & Explosive Profit Growth - earlytimes.in

Nov 26, 2025

Nov 24, 2025

CervoMed Inc. to Present Phase 2b Trial Results of Neflamapimod for Dementia with Lewy Bodies at CTAD Conference - Quiver Quantitative

Nov 24, 2025

Nov 24, 2025

CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference - Sahm

Nov 24, 2025

Nov 19, 2025

CervoMed Executives Make Bold Moves with Major Stock Purchases! - TipRanks

Nov 19, 2025

Nov 19, 2025

Will CervoMed Inc. stock outperform Nasdaq indexWeekly Gains Summary & Free Technical Pattern Based Buy Signals - newser.com

Nov 19, 2025

Nov 19, 2025

CervoMed Inc. Stock (CRVO) Opinions on Insider Buying and Clinical Trial Progress - Quiver Quantitative

Nov 19, 2025

Nov 19, 2025

CervoMed Inc. stock retracement – recovery analysisChart Signals & Smart Money Movement Tracker - newser.com

Nov 19, 2025

Nov 19, 2025

Will CervoMed Inc. (DP8) stock deliver compounding returns2025 Top Decliners & Verified Swing Trading Watchlist - newser.com

Nov 19, 2025

Nov 19, 2025

CervoMed Inc.: Chief commercial officer Winton buys $41k in CRVO - Investing.com Australia

Nov 19, 2025

Nov 19, 2025

CervoMed CEO Alam buys shares worth $182,736 By Investing.com - Investing.com Australia

Nov 19, 2025

Nov 19, 2025

Elder William buys CervoMed (CRVO) stock worth $29,250 By Investing.com - Investing.com Canada

Nov 19, 2025

Nov 19, 2025

Insider Buying: Matthew Winton Acquires Additional Shares of Cer - GuruFocus

Nov 19, 2025

Nov 19, 2025

Gregoire Sylvie buys CervoMed (CRVO) shares worth $182,736 By Investing.com - Investing.com Canada

Nov 19, 2025

Nov 19, 2025

CervoMed Inc.: Chief commercial officer Winton buys $41k in CRVO By Investing.com - Investing.com South Africa

Nov 19, 2025

Nov 19, 2025

Elder William buys CervoMed (CRVO) stock worth $29,250 - Investing.com

Nov 19, 2025

Nov 19, 2025

CervoMed CEO Alam buys shares worth $182,736 - Investing.com India

Nov 19, 2025

Nov 19, 2025

Tools to monitor CervoMed Inc. recovery probabilityJuly 2025 Recap & AI Based Trade Execution Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

[Form 4] CervoMed Inc. Insider Trading Activity - Stock Titan

Nov 19, 2025

Nov 19, 2025

How to integrate CervoMed Inc. into portfolio analysis toolsMarket Growth Summary & Real-Time Chart Breakout Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

CervoMed Inc. stock trend outlook and recovery pathTake Profit & Fast Exit/Entry Strategy Plans - newser.com

Nov 19, 2025